The Business Behind...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$98.54 0.09 | 0.09%
05/21/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 2.70B | 2.41B | 1.99B | 1.95B |
| Receivables | 764.20M | 730.60M | 647.30M | 576.60M |
| Inventories | 282.90M | 249.70M | 229.40M | 213.90M |
| Other Current Assets | 50.30M | 482.00M | 376.70M | 368.70M |
| Total Current Assets | 4.46B | 4.05B | 3.99B | 3.11B |
| Property, Plant & Equipment, Gross | 1.66B | 1.53B | 1.45B | 1.37B |
| Accumulated Depreciation & Depletion | 804.70M | 722.20M | 646.70M | 559.20M |
| Property, Plant & Equipment, Net | 852.90M | 807.00M | 800.60M | 808.10M |
| Intangibles | 1.23B | 1.17B | 996.00M | 1.36B |
| Other Non-Current Assets | 192.10M | 247.10M | 261.40M | 266.70M |
| Total Non-Current Assets | 4.72B | 4.46B | 4.31B | 4.43B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 9.18B | 8.51B | 8.31B | 7.54B |
| Accounts Payable | 233.10M | 200.40M | 222.50M | 204.00M |
| Short Term Debt | 0.00 | 0.00 | 642.50M | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 16.10M | 42.50M |
| Total Current Liabilities | 1.10B | 955.00M | 1.53B | 811.60M |
| Long Term Debt | 1.51B | 1.52B | 1.53B | 1.49B |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 1.40M |
| Other Non-Current Liabilities | 709.10M | 705.80M | 464.40M | 388.40M |
| Minority Interest | 3.70M | 3.60M | 4.30M | 2.50M |
| Total Non-Current Liabilities | 2.25B | 2.24B | 2.02B | 1.90B |
| Total Liabilities | 3.34B | 3.20B | 3.55B | 2.71B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 5.84B | 5.31B | 4.76B | 4.82B |
| Common Par | 3.10M | 3.10M | 3.10M | 3.10M |
| Additional Paid In Capital | 2.90B | 2.76B | 2.82B | 2.73B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 3.83B | 2.97B | 2.23B | 2.36B |
| Treasury Stock | -654.10M | -183.20M | -133.90M | -164.50M |
| Other Equity Adjustments | -244.60M | -241.40M | -152.90M | -102.80M |
| Total Capitalization | 7.35B | 6.82B | 6.29B | 6.31B |
| Total Equity | 5.84B | 5.31B | 4.76B | 4.82B |
| Total Liabilities & Stock Equity | 9.18B | 8.51B | 8.31B | 7.54B |
| Total Common Shares Outstanding | 300.32M | 305.27M | 305.52M | 304.43M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 7.21M | 2.25M | 1.99M | 3.08M |
| Basic Weighted Shares Outstanding | 301.50M | 304.40M | 303.40M | 303.60M |
| Diluted Weighted Shares Outstanding | 307.10M | 310.20M | 308.00M | 305.80M |
| Number of Employees | 10800 | 10000 | 9200 | 8300 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AGN
- Portfolio NameUser Type
- ProRay Dalio - Bridgewater Ass...
- ContributorHigh Volume Technicals for ...
- ContributorTechnical Setups for the We...
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
Latest AGN Headlines from TheStreet
- 4 Stocks Going Ex-Dividend Tomorrow: PGH, NTI, MAT, AGN 05.20.13 | 10:05 am
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) 05.20.13 | 09:05 am
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Laggard 05.08.13 | 05:05 pm
- Mad Money Uncovered: Allergan
05.08.13 | 06:05 am - 'Mad Money' Lightning Round: Discover Financial Is Cheap -- Buy It 05.07.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Timing Is Everything 05.06.13 | 08:05 pm
- It's Pipeline That Matters Most 05.04.13 | 04:05 am
- Cramer's Top Stock Picks: AGN BP CRL PRU AIG 05.03.13 | 06:05 am
- Cramer's 'Mad Money' Recap: A New Dawn for Europe? 05.02.13 | 08:05 pm
Press Releases for AGN
- Allergan, Inc. Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc. And Intent To Exercise Top-Up Option To Effect A Short-Form Merger - Business Wire 03.01.13 | 09:03 am
- FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants - Business Wire 02.20.13 | 06:02 pm
- Allergan, Inc. And MAP Pharmaceuticals, Inc. Announce The Federal Trade Commission Has Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act - Business Wire 02.07.13 | 09:02 am
- Allergan Reports Fourth Quarter 2012 Operating Results - Business Wire 02.05.13 | 09:02 am
- Allergan Commences Cash Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals - Business Wire 01.31.13 | 09:01 am
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - PR Newswire 01.25.13 | 03:01 pm
- MAP Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Allergan, Inc. - PR Newswire 01.23.13 | 11:01 am
- Allergan, Inc. To Acquire MAP Pharmaceuticals, Inc. - Business Wire 01.22.13 | 08:01 pm
- BOTOX(R) (onabotulinumtoxinA) Receives U.S. Food And Drug Administration Approval For The Treatment Of Overactive Bladder For Adults Who Have An Inadequate Response To Or Are Intolerant Of An Anticholinergic Medication - Business Wire 01.18.13 | 05:01 pm
- Allergan Announces Quarterly Conference Call - Business Wire 01.07.13 | 05:01 pm
Partner Headlines for AGN
- Apache, Windstream and Other Stocks Insiders Are Buying - Benzinga 04.06.13 | 12:04 pm
- Johnson & Johnson's Quest to Knock Botox off the Pedestal - Benzinga 03.22.13 | 02:03 pm
- Acadia Forges Forward With Pimavanserin - Seeking Alpha 03.13.13 | 09:03 am
- Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying - Benzinga 03.09.13 | 02:03 pm
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for February 26, 2013 - NASDAQ 02.22.13 | 02:02 pm
- Why I Sold Allergan - Seeking Alpha 02.01.13 | 07:02 pm
- How To Play The Cosmeceutical Market - Seeking Alpha 12.25.12 | 09:12 am
- Buy MAP Pharmaceutical For 70% Upside - Seeking Alpha 11.26.12 | 09:11 am
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for November 19, 2012 - NASDAQ 11.15.12 | 02:11 pm
